Alpha2-adrenoceptor agonists
Sanders, R.D.; Maze, M.
Current Opinion in Investigational Drugs 8(1): 25-33
2007
ISSN/ISBN: 1472-4472 PMID: 17263182 Document Number: 612497
Alpha2-Adrenoceptor agonists have an immensely diverse utility in peri-operative and critical care medicine. In particular, their application as premedicants, analgesics and hypnotics/sedatives is becoming increasingly popular with delivery to a wide spectrum of patients. The ability of these agents to provide renal, cardiac and neurocognitive protection is only just being realized and requires further study.
Document emailed within 1 workday
Related Documents
Schmidt-Oechtering, G.U.; Becker, K. 1992: Old and new alpha 2-adrenoceptor agonists. 1. Xylazine and medetomidine Tierarztliche Praxis 20(5): 447-458Kaplan, N.M. 1985: Alpha 2-adrenoceptor agonists in the treatment of hypertension Journal of Cardiovascular Pharmacology 7(Suppl 8): S64-S66
Angel, I.; Bidet, S.; Langer, S.Z. 1988: Pharmacological characterization of the hyperglycemia induced by alpha-2 adrenoceptor agonists Journal of Pharmacology and Experimental Therapeutics 246(3): 1098-1103
Svensson, T.H. 1987: Stress, central neurotransmitters, and the mechanism of action of alpha 2-adrenoceptor agonists Journal of Cardiovascular Pharmacology 10(Suppl 12): S88-S92
Ruffolo, R.R.; Turowski, B.S.; Patil, P.N. 1977: Lack of cross-desensitization between structurally dissimilar alpha-adrenoceptor agonists Journal of Pharmacy and Pharmacology 29(6): 378-380
Blandford, D.E.; Smyth, D.D. 1990: Role of vasopressin in response to intrarenal infusions of alpha-2 adrenoceptor agonists Journal of Pharmacology and Experimental Therapeutics 255(1): 264-270
Dollery, C.T. 1976: Centrally acting alpha-adrenoceptor agonists in hypertension: mechanisms and their role in therapy Australian and New Zealand Journal of Medicine 6(3): 88-94
Tabrizchi, R.; Triggle, C.R. 1992: The interrelationship between the effects of captopril and nifedipine on pressor responses elicited by selective alpha-adrenoceptor agonists in the pithed rat preparation Journal of Cardiovascular Pharmacology 19(4): 562-567
Donello, J.E.; Padillo, E.U.; Webster, M.L.; Wheeler, L.A.; Gil, D.W. 2001: Alpha(2)-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia Journal of Pharmacology and Experimental Therapeutics 296(1): 216-223
Wiśniewska, R.J. 1998: Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A Polish Journal of Pharmacology 50(3): 203-212
Martin, D.J.; Lluel, P.; Guillot, E.; Coste, A.; Jammes, D.; Angel, I. 1997: Comparative alpha-1 adrenoceptor subtype selectivity and functional uroselectivity of alpha-1 adrenoceptor antagonists Journal of Pharmacology and Experimental Therapeutics 282(1): 228-235
Shi, C.Z.; Li, X.M.; Liu, Y.; Zhang, J.T. 1990: Application of mouse tail artery for the study of alpha adrenoceptor agonists and antagonists and calcium antagonists Yao Xue Xue Bao 25(3): 223-226
Weetman, D.F.; Jahn, U.; Ismail, S.; Chadwick, M.A.; Coates, J.; Lawson, K.; Turner, N.; Thiele, K. 1983: Sgd 101/75: a sympathomimetic that can be used to identify a new subtype of alpha-adrenoceptor, the alpha 1s-adrenoceptor Methods and Findings in Experimental and Clinical Pharmacology 5(7): 425-434
Miyagishi, A.; Nakahara, H.; Hara, Y. 1984: Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent Archives Internationales de Pharmacodynamie et de Therapie 271(2): 249-262
Spadari, R.C.; De-Moraes, S. 1987: Aging and rat pacemaker sensitivity to beta-adrenoceptor agonists Brazilian Journal of Medical and Biological Research 20(5): 591-594
Vassilev, P.P. 1995: Beta-Adrenoceptor agonists-induced desensitization in rat trachea Acta Physiologica et Pharmacologica Bulgarica 21(3): 57-62
Dawson, J.R.; Bayliss, J.; Norell, M.S.; Canepa-Anson, R.; Kuan, P.; Reuben, S.; Poole-Wilson, P.A.; Sutton, G.C. 1982: Clinical studies with beta 2 adrenoceptor agonists in heart failure European Heart Journal 3 Suppl D: 135-141
Canepa-Anson, R.; Dawson, J.R.; Frankl, W.S.; Kuan, P.; Sutton, G.C.; Reuben, S.; Poole-Wilson, P.A. 1982: Beta 2 adrenoceptor agonists. Pharmacology, metabolic effects and arrhythmias European Heart Journal 3 Suppl D: 129-134
Wurch, T.; Okuda, J.; Pauwels, P.J. 2001: Reciprocal modulation of alpha(2A)-adrenoceptor and G(alpha o) protein states as determined by carboxy-terminal mutagenesis of a G(alpha o) protein Molecular Pharmacology 60(4): 666-673
Hedberg, A.; Mattsson, H. 1981: Beta adrenoceptor interaction of full and partial agonists in the cat heart and soleus muscle Journal of Pharmacology and Experimental Therapeutics 219(3): 798-808